Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kathleen Proudfoot"'
Autor:
Kathleen Proudfoot, Shmuel Shoham, Angela Ademposi, Rachel J. Hagey, Charles Fiorentino, Susan Reed, Tyler Bristol, Rani Athota, Jeffery K. Taubenberger, Matthew J. Memoli, Lindsay Czajkowski, Jocelyn Voell
Publikováno v:
Clinical Infectious Diseases
During the past half-century, medical advances have led to an increase in the world's population of immunosuppressed individuals. This includes those receiving immunosuppressive therapies, those with acquired immunosuppressive diseases such as the 34
Autor:
Kathleen Proudfoot, Matthew J. Memoli, A. Sally Davis, Tyler Bristol, Eleca J. Dunham, Jeffery K. Taubenberger
Publikováno v:
Virology. 428(1):21-29
The influenza A(H1N1)pdm09 virus has circulated worldwide and continued to cause complicated infections and deaths. Reports have identified an increased prevalence of the hemagglutinin receptor binding domain D222G mutation in viruses isolated from i
Autor:
Daniel A. Katzel, Xudong Lin, David J. Spiro, Jay V. DePasse, Kathleen Proudfoot, Larry Overton, Bridget Szczypinski, Jeffrey Sitz, Sara Griesemer, Kirsten StGeorge, David E. Wentworth, Adam Fitch, Erin Hine, Edward C. Holmes, Jayati Bera, Elodie Ghedin, Rebecca A. Halpin
Publikováno v:
Journal of Virology. 84:5715-5718
The initial wave of swine-origin influenza A virus (pandemic H1N1/09) in the United States during the spring and summer of 2009 also resulted in an increased vigilance and sampling of seasonal influenza viruses (H1N1 and H3N2), even though they are n
Autor:
Lindsay Czajkowski, Matthew Stein, Kathleen Proudfoot, Richard T. Davey, Jeffery K. Taubenberger, Sarah Fargis, Rani Athota, Tyler Bristol, Rebecca L. Dunfee, Matthew J. Memoli, Susan Reed, Pamela A. Shaw
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 60(5)
Background. Healthy volunteer wild-type influenza challenge models offer a unique opportunity to evaluate multiple aspects of this important virus. Such studies have not been performed in the United States in more than a decade, limiting our capabili
Autor:
Rachel J. Hrabal, Matthew J. Memoli, Daniel S. Chertow, A. Sally Davis, Tyler Bristol, Jeffery K. Taubenberger, Kathleen Proudfoot
Publikováno v:
The Journal of infectious diseases. 203(3)
Influenza A viruses are significant human pathogens, both in their sporadic pandemic and endemic (seasonal) forms. Antiviral therapies are commonly used to treat both severe illness in high-risk patients and self-limited influenza infection. Widespre
Autor:
Timothy B. Stockwell, Cécile Viboud, Erin Hine, Eric T. Beck, Rebecca A. Halpin, David J. Spiro, Xudong Lin, Kathleen Proudfoot, Sara Griesemer, Elodie Ghedin, David E. Wentworth, Martha I. Nelson, Edward C. Holmes, Michael E. Bose, Jiang Fan, Kelly J. Henrickson, Swati Kumar, Jayati Bera
Publikováno v:
PLoS Currents
Background Since its initial detection in April 2009, the A/H1N1pdm influenza virus has spread rapidly in humans, with over 5,700 human deaths. However, little is known about the evolutionary dynamics of H1N1pdm and its geographic and temporal divers
Autor:
Jeffery K. Taubenberger, Tyler Bristol, Kathleen Proudfoot, Rachel J. Hrabal, Matthew J. Memoli, A. Sally Davis, Daniel S. Chertow
Publikováno v:
Journal of Infectious Diseases. 204:1642-1643
TO THE EDITOR—Abed and colleagues [1] stress the importance of rigorous evaluation of new antivirals for patients infected with influenza viruses that have developed resistance to approved antiviral drugs. They suggest that the observed shift in su